Fig. 1From: Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium modelKaplan-Meier curves showing PFS, OS, and CSS. Kaplan-Meier curves for (A) PFS for first-line systemic therapy, (B) PFS for second-line systemic therapy, (C) OS from the initiation of first-line systemic therapy, and (D) CSS from the initiation of first-line systemic therapy in mRCC patients ≥75 years and those < 75 years. + censored caseBack to article page